Rising Number of Flu Cases Could Elevate These ETFs
Cases of the flu have reached elevated levels as of late. This could keep healthcare stocks and ETFs with a healthcare focus on the radar for traders.
5 Leveraged ETFs That Witnessed Double-Digit Gains in January
We highlight a bunch of the best-performing leveraged equity ETFs of January.
CURE: Analyst Estimates Point To Significant Gains In 2025
The Direxion Daily Healthcare Bull 3X Shares ETF seeks to deliver 300% (3x) of the return of an index focused on large-cap US healthcare stocks. Since October 2024 the forward P/E ratio for CURE's largest holdings has marginally increased. Even so Wall Street analysts predict a weighted average gain of 21% for CURE's top ten components over the next 12 months.
There Could Be Value in Healthcare Stocks Ahead of 2025
When a new presidential administration is set to take office, there's uncertainty as to whether specific sectors could be impacted. In the case of healthcare, that's certainly the case, especially in biotech.
CURE: A Leveraged ETF To Own Throughout This Century
The Direxion Daily Healthcare Bull 3X Shares ETF seeks to deliver 300% of the performance of an index heavily concentrated in large-capitalization US healthcare stocks. CURE's top ten holdings trade at a weighted average forward P/E of 28.27, with analysts predicting a 9.78% gain over the next 12 months. The healthcare sector benefits from long-term trends such as an aging population and an increased focus on longevity. Artificial intelligence will also help in developing new treatments.
5 Leveraged ETFs With Double-Digit Gains in August
After witnessing steep sell-offs at the start of August, all three major indices end the month with double-digit gains.
